Cystic Fibrosis Clinical Trial
Official title:
Effect of a Family Empowerment Program on Coping With Stress, Problem Solving in Parents, and Quality of Life in Children With Cystic Fibrosis: Randomized Controlled Trial
Parents of children with cystic fibrosis (CF) experience high levels of stress and problems.
Family empowerment interventions provide important support for many patients with CF and
their families. However,there is a lack of research exploring the effects of such empowerment
programs on coping, and Problem Solving among parents, and Quality of Life in Children with
CF.
The present study aimed to assess the effect of a family empowerment program-based nursing
intervention on parents coping with stress and problem solving, and quality of life children
with CF.
Parents of children with cystic fibrosis (CF) experience high levels of stress and problems.
Family empowerment interventions provide important support for many patients with CF and
their families. However,there is a lack of research exploring the effects of such empowerment
programs on coping, and Problem Solving among parents, and Quality of Life in Children with
CF. The present study aimed to assess the effect of a family empowerment program-based
nursing intervention on parents coping with stress and problem solving, and quality of life
children with CF.
A single-blinded, parallel group pretest and posttest design randomized controlled trial was
used.
Data were collected over 5 months (January 2017-May 2017) from 48 participants in a medical
faculty hospital. They were randomly assigned to the experimental (n = 24) and control (n =
24) groups. Nursing interventions applied to the experimental group for ten weeks with the
intent of strengthening families consist of; providing individualized training and booklet
concerning disease management and providing phone calls and consultancy services for the
purpose of reinforcing the training and increasing the motivation. A routine polyclinic
follow-up was applied to the control group. Problem Solving Inventory (PSI), Scale of Ways of
Coping with Stress (SWCS), and The Cystic Fibrosis Questionnaire-Revised scale (CFQ-R) were
used reliable and valid instruments. The data were evaluated using the Wilcoxon Signed Ranks
test in evaluating dependent groups and the Mann-Whitney U test in independent groups.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |